To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver Metastases

Inclusion Criteria

• •Age: ≥18 years old
• •Gender: no limitation
• •Histologically or cytologically documented advanced colorectal carcinoma with unresectable liver metastasis (existence of extrahepatic metastasis is acceptable)
• •Subjects must have at least one measurable lesion per RECIST v1.1
• •Patients only received treatment with HepaSphere combined with hepatocellular arterial infusion chemotherapy (HAIC) as interventional therapy during the observation period
• •Child-Pugh: A-B
• •ECOG: 0-2.